HIV-Positive People Taking HAART Less Likely to Experience Brain Damage, Study Says
October 10, 2007
HIV-positive people taking highly active antiretroviral therapy are less likely to experience brain damage associated with the virus, according to a study published in the Oct. 9 issue of the journal Neurology, Reuters reports.
HAART "appears to halt the neurodegenerative process caused by HIV," Mellgren said, adding that the study "confirms that NLP serves as a useful marker in monitoring brain injury in people with HIV and in evaluating the effectiveness of HAART" (Reuters, 10/8).
An abstract of the study is available online.
HIV-Infected Patients Who Have the ApoE4 Allele Are More Vulnerable to the Effects of Low CD4 Counts
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.